Therapeutic Proteins to 2014Greystone Research AssociatesNovember 15, 2010 155 Pages - SKU: GRST2880002 |
- Executive Summary
- Protein Therapeutics Market Dynamics
- Biological Drugs - The Risks & the Opportunities
- The Protein Therapeutics Marketspace
- Clinical Trials and Drug Approvals
- The Competitive Landscape
- Demographics, Managed Care and Growth
- Therapeutic Protein Commercialization - Success Factors
- Formulating Protein Drugs
- Formulation Strategies
- Stability
- Half-Life & Therapeutic Protocols
- Immunogenicity
- Protein Formulation Technologies
- Post-translational Modification
- Encapsulation Technologies
- Lyophilization
- Dosing Frequency and Treatment Compliance
- Protein Packaging & Delivery
- Injection
- Pen Injectors - Dominant in Chronic Disease
- Prefilled Syringes - Cost and Quality of Care
- Emerging Protein Injection Options
- Inhalation
- Dry Powder Inhalers - Stability at a Price
- Sprays/Aerosols - The Technical Challenges
- Development-stage Packaging & Delivery Technologies
- Oral
- Proprietary Processes and Pipeline Prospects
- Commercialization Potential & Risk Factors
- Transdermal
- Active Transdermal - The Shrinking Footprint
- Microneedles - Engineering & Economics
- Protein Drug Distribution Strategies
- Protein Drugs - Drug Classes and Therapeutic Targets
- Antibodies
- Enzymes
- Growth Factors
- Hematopoietics
- Hormones
- Immune Modulators
- Other Protein Therapy Classes
- Protein Drug Therapeutics - Disease Segment Analysis & Forecasts
- Autoimmune Diseases
- Dominance of Antibodies & Cytokines
- B-Cell Depleting Agents
- Interferons
- Interleukin Receptor Agonists
- TNF Inhibitors
- T-Cell Blocking Agents
- Development-stage Candidates
- Demand Patterns and Forecasts
- Hematology
- Anemia
- Hemoglobinuria
- Thrombocytopenia
- Demand Patterns and Forecasts
- Hereditary Diseases
- Infectious Diseases
- Hepatitis
- RSV
- Demand Patterns and Forecasts
- Hormone Replacement
- Increasing Competition in a Crowded Market
- Demand Factors and Forecasts
- Oncology
- Key Therapeutic Sectors & Therapeutic Target Selection
- Expanding Indications & Therapeutic Endpoints
- Leading Oncology Protein Drug Products
- Pipeline Candidates
- Demand Data and Forecasts
- Reproductive Medicine
- Dominance of Leutinizing Hormones
- Demand Data and Forecasts
- Transplantation/Organ Rejection
- Approve Protein Drugs
- The Market Opportunity
- Emerging Therapeutic Segments
- Market and Regulatory Factors
- Regulatory Issues
- Ease-of-Use and Patient Compliance
- IP and Biosimilars
- Protein Drug Therapeutics - Company Profiles
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Research & Development Reports
- Personalized Medicine Market Analysis
- Biotechnology in the US - Industry Risk Rating Report
- Pharmacogenomics Partnering Terms and Agreements
- Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)
- Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017